Targeting tumor cell signaling and proliferation is a major strategy in classical and novel cancer therapies. Multiple cytotoxic and targeted drugs aim to prevent cancer cell proliferation or to eliminate cells undergoing DNA replication or mitosis. Despite the initial success of these strategies, resistance mechanisms are common, especially in patients with metastatic disease. Beyond cancer cell autonomous mechanisms, there is good evidence that cells from the tumor stroma can also contribute to therapy resistance.
This 42nd edition of the Biomed conferences will bring basic and translational scientists together with clinicians to discuss the latest findings on how tumors respond to therapies and develop resistance, as well the challenges of monitoring therapy resistance in the clinic and finding effective therapeutic strategies.
Topics will include mechanistic studies, genetic analysis, evolutionary dynamics and the contribution of the tumor microenvironment, as well as new approaches to monitoring and tackling therapy resistance in the clinic. We strive to create a highly focused think‐tank atmosphere for a select group of attendees to concentrate on the challenges of understanding resistance mechanisms and finding novel therapeutic strategies.
Presentation
Conference organizers
Dr. Angel R. Nebreda
IRB Barcelona/ICREA
Barcelona, Spain
Dr. Clare M. Isacke
ICR
London, UK
Dr. Marcos Malumbres
VHIO/ICREA
Barcelona, Spain
There is no registration fee for this conference, but the number of participants is limited, with a number of seats saved for IRB Barcelona alumni. Previous registration is required.
Priority will be given to those who submit the highest quality abstracts for short talks or posters and the order of registration will be considered.
Abstracts should include a title, authors, affiliations, summary (max 250 words) and references
REGISTRATION DEADLINE: 1 OCTOBER, 2024
(Note: Any issue about the registration or abstract, please contact: meritxell.gavalda@irbbarcelona.org)
Venue
The BARCELONA BIOMED CONFERENCE Molecular Determinants of Cancer Therapy Resistance will be placed at the Casa Convalescència in the heart of Barcelona. Talks will take place in the Aula Magna.
Casa Convalescència
C/ Sant Antoni Maria Claret, 171
08041 Barcelona
Tel +34 934 335 000
https://www.uab.cat/casa-convalescencia/
How to reach the Casa Convalescència:
Underground
Yellow line (L4) - GUINARDÓ – HOSPITAL DE SANT PAU station
Blue line (L5) - SANT PAU – DOS DE MAIG station
By bus
Lines: 15, 19, 20, 45, 47, 50, 51, 92 and 192.
For the GPS
Introduce the following coordinates:
Latitude: 41.413702 (41° 24' 49.33'' N)
Longitude: 2.177482 (2° 10' 38.94'' E)
From the airport
* Train + Underground. At the RENFE station, take the train to Sants-Estació. Once there take the Underground's blue line (L5) till SANT PAU – DOS DE MAIG station.
* Bus + Underground. Outside the airport terminal, take the AEROBUS to Plaça Catalunya. Walk one corner till Plaça Urquinaona and take the Underground's yellow line (L4) to GUINARDÓ – HOSPITAL DE SANT PAU station.
Barcelona Metropolitan Transport webiste (with metro and bus maps)
Accomodation
Speakers will be lodged at the Hotel Catalonia Sagrada Familia
Aragó 577- 579
08026, Barcelona
Telephone: +34 93 245 89 05
www.cataloniahotels.com/en/
Other hotels
A list of additional hotels within walking distance of the Casa Convalescència can be found at: https://www.barcelona-tourist-guide.com/en/hotels/hotelmaps/eixample-right-barcelona-hotel.html
(The Casa Convalescència is located near the violet point 27/3 star). Rates will vary depending on choice of hotel and season. Please check with the hotel of your choice directly for the best offer.
Residences
Another possibility is the Lesseps Residence Hall, and is available for short-term stays.
Lesseps Residence Hall
Plaza Lesseps, 12 08023 Barcelona
View on map
Telephone: +34 933 941 600
e-mail: lesseps@resa.es
www.resa.es/en/city/barcelona
Participants registered for events in the Barcelona BioMed series should contact the hotels and residences directly to arrange bookings and payment.
Speakers
Dr. Jean Albrengues
IRCAN (Nice, France)
Dr. James Arnold
King's College London (London, UK)
Dr. Eduard Batlle
IRB Barcelona/ ICREA (Barcelona, Spain)
Dr. Alexis Barr
MRC London Institute of Medical Sciences (London, UK)
Dr. Thijn Brummelkamp NKI (Amsterdam, The Netherlands)
Dr. Aura Carreira
CBMSO (Madrid, Spain)
Dr. Oskar Fernandez-Capetillo
CNIO (Madrid, Spain)
Dr. Michael Hemann
Koch Institute for Integrative Cancer Research at MIT (Cambridge, MA, USA)
Dr. Nada Y. Kalaany
Harvard Medical School- Boston Children's Hospital (Boston, MA, USA)
Dr. Francisco Martínez-Jiménez VHIO (Barcelona, Spain)
Dr. Nicholas McGranahan
UCL (London, UK)
Dr. Yaara Oren
TAUEX (Tel-Aviv, Israel)
Dr. Luis Paz-Ares
SEOM (Madrid, Spain)
Dr. Violeta Serra
VHIO (Barcelona, Spain)
Dr. Yuval Shaked
Technion- Israel Institute of Technology (Haifa, Israel)
Dr. Anna Vähärautio
University of Helsinki (Helsinki, Finland)
Poster
